Safest Nasal Sprays During Pregnancy
Intranasal corticosteroid sprays are safe and recommended during pregnancy, with budesonide being the preferred first choice due to its Pregnancy Category B classification and extensive human safety data. 1
Primary Recommendations
First-Line: Intranasal Corticosteroids
Budesonide nasal spray is the safest option when starting treatment during pregnancy, as it has:
- Pregnancy Category B classification
- Extensive human safety data demonstrating no increased risk of major malformations, preterm delivery, low birth weight, or pregnancy-induced hypertension 1
- The most robust evidence base among all intranasal corticosteroids 1
If already using another intranasal corticosteroid before pregnancy (such as fluticasone propionate, mometasone, or beclomethasone), it is reasonable to continue the same medication that has been controlling symptoms effectively 1. Meta-analyses show no convincing evidence of congenital defects with these agents 1.
The 2020 EPOS guidelines specifically recommend continuing nasal corticosteroid sprays for chronic rhinosinusitis maintenance during pregnancy 2.
Second-Line: Sodium Cromolyn
Sodium cromolyn nasal spray is a safe alternative with:
- Pregnancy Category B classification
- Reassuring human and animal gestational data
- Topical application with minimal systemic absorption 1
Limitation: Requires 4 times daily dosing and has reduced efficacy compared to intranasal corticosteroids, limiting patient acceptance 1.
What to Avoid
Topical Decongestants
Avoid or use only short-term (up to 7 days maximum). The safety data for intranasal decongestants (oxymetazoline, phenylephrine) during pregnancy has not been adequately studied 1. While they may have a better safety profile than oral decongestants for first trimester use, data remain insufficient 1.
Intranasal Antihistamines
Avoid during pregnancy. Limited data exist for azelastine and levocetirizine, and these should not be used 3.
Off-Label Formulations
Do not use budesonide irrigations or corticosteroid nasal drops during pregnancy—these are off-label uses without safety data 4.
Key Safety Considerations
Timing matters: First trimester exposure carries the greatest theoretical concern for teratogenicity, though modern intranasal corticosteroids have not demonstrated this risk in human studies 1.
Dose optimization: Use the lowest effective dose to maintain symptom control 1.
Systemic absorption: Intranasal corticosteroids have much lower systemic exposure compared to oral or inhaled corticosteroids, making them particularly safe 1.
Breastfeeding: Intranasal corticosteroids are compatible with breastfeeding 5.
Non-Pharmacologic First Option
Before any medication, consider hypertonic saline nasal rinses—these are completely safe with no fetal risk and demonstrate significant efficacy for pregnancy-induced rhinitis and seasonal allergic rhinitis 6, 7. One randomized study showed statistically significant improvement in rhinitis scores and reduced antihistamine use in pregnant women using hypertonic saline 3 times daily 7.
Common Pitfalls to Avoid
- Don't withhold intranasal corticosteroids due to pregnancy concerns—the evidence strongly supports their safety, and undertreated maternal symptoms may pose greater risks 4
- Don't switch medications unnecessarily—if a patient is well-controlled on a specific intranasal corticosteroid pre-pregnancy, continuation is appropriate 1
- Don't use intranasal triamcinolone—one study found a significant association with respiratory tract defects 8
- Don't prescribe oral decongestants, especially in the first trimester, due to associations with gastroschisis and small intestinal atresia 1